JMM Correspondence
Identification of international circulating lineages of meticillin-resistant Staphylococcus aureus in the north of Spain and their glycopeptide and linezolid susceptibility Meticillin-resistant Staphylococcus aureus (MRSA) represents one of the main nosocomial pathogens at present. The increasing prevalence of multidrug resistance and the emergence of isolates with intermediate or high-level vancomycin resistance emphasize the importance of the use of infection control measures (Vindel et al., 2009) . In Spain, the prevalence of MRSA has increased since the 1990s and in some cases has now reached levels higher than 30 % (Cuevas et al., 2008) .
Historically, the dissemination of epidemic clones such as EMRSA type 15 (EMRSA-15), EMRSA-16, the Iberian clone and the Brazilian clone, as well as the high incidence of the community-acquired MRSA USA300 clone, have led to the increased use of molecular typing methods (Vindel et al., 2009) .
The aim of the present study was to determine the circulating clones in the north of Spain and their antimicrobial susceptibility. A total of 455 MRSA isolates were collected in 16 Spanish hospitals over a 4-month period (February-May 2009) and included in this analysis. One sample was taken per patient, and the isolates were mainly from the respiratory tract and wounds.
All strains carried the mecA gene, as confirmed by PCR (Milheiriço et al., 2007) , and all strains were negative for the Panton-Valentine leukocidin (McClure et al., 2006) .
The MRSA isolates were characterized by spa-sequence typing (Harmsen et al., 2003) with BURP analysis (Mellmann et al., 2007) , staphylococcal cassette chromosome mec typing (SCCmec) (Milheiriço et al., 2007) , multilocus sequence typing (MLST) and BURST analysis (http://saureus.mlst.net).
spa typing revealed 43 different types. The predominant spa types were t067 (41.5 %), t002 (32.3 %), t008 (7.7 %) and t148 (3.1 %). spa types t003, t032, t837, t1080, t2220 and t5293 represented ,2 %, and t010, t011, t018, t019, t022, t024, t045, t059, t062, t064, t068, t080, t081, t084, t109, t121, t211, t304, t359, t686, t688, t747, t756, t1080, t1399, t1510, t2226, t3618, t3678, t3746, t5160, t6452, t6475 and the new spa type t7399 represented ,0.5 %.
By application of the BURP algorithm, the MRSA strains were clustered into three groups, spa-clonal complex 067 (spa-CC067; 82.9 %), spa-CC008 (9.5 %) and spa-CC022 (2.2 %), and 10 strains were singletons (5.1 %). spa type t059 was excluded. CC067 included the two predominant spa types (t067 and t002).
SCCmec type IV accounted for 87.5 % of the isolates whereas SCCmec type II accounted for 11.2 %. SCCmec types III and I were found in 0.9 and 0.4 % of isolates, respectively. Three strains were nontypable.
MLST revealed 21 different sequence types (STs). The predominant STs were ST125 (44.6 %), ST5 (35.4 %), ST8 (9.7 %), ST72 (3.3 %) and ST22 (2.4 %). The other STs, ST15, ST25, ST34, ST36, ST146, ST225, ST228, ST641, ST669 and ST903 and six new MLST STs (ST2092, ST2093, ST2101, ST2102, ST2103 and ST21), represented ,2 %. One new allele was found and was designated aroE309. By BURST analysis, the MRSA strains were clustered into four groups, ST-clonal complex 5 (ST-CC5; 81.8 %), ST-CC8 (9.8 %), ST-CC22 (2.6 %) and ST-CC30 (1.5 %), and six strains were singletons.
Of the MRSA strains in ST-CC5, 99.6 % were spa-CC067.
The distribution and correlation of the different SCCmec types, spa types, spa-CCs and MLST types (ST and ST-CC) are shown in Table 1 .
Antimicrobial susceptibility for ciprofloxacin (CIP), erythromycin (ERY), tobramycin (TOB), clindamycin (CLIN), mupirocin (MUP), gentamicin (GEN), rifampicin (RFP) and cotrimoxazole (SXT) was determined by the broth microdilution (VITEK 2 AST-P588 cards; bioMérieux) and disc diffusion (DD) methods according to Clinical and Laboratory Standards Institute (CLSI, 2011) breakpoints. The DD method and Etest method (bioMérieux), in accordance with CLSI guidelines, were also performed for linezolid (LNZ), vancomycin (VAN) and teicoplanin (TEI) MIC determination. The percentages of resistant isolates were as follows: CIP (99.6), ERY (53.4), TOB (44.6), CLIN (23.7) (14.7 % MLS B i, 9 % MLS B c), MUP (12.7), GEN (8.4) and RFP (0.9). All isolates were susceptible to SXT.
The VAN, TEI and LNZ MIC 50/90 values (Etest) were 2/2, 2/2 and 1/2 mg l 21 , respectively. A VAN MIC of 3, 2, 1.5 and ¡1 mg l 21 was shown by 7.2 %, 44 %, 40.2 % and 8.4 % of the strains, respectively. It is important to emphasize that the Etest method appears to be relatively more reliable in predicting treatment response and yielded higher MICs for strains with a heterogeneous vancomycin-intermediate S. aureus phenotype (Hsu et al., 2008) .
All the aminoglycoside-resistant isolates were screened for the presence of the genes encoding the most clinically relevant aminoglycoside-modifying enzymes by multiplex PCR (Schmitz et al., 1999) . The present study revealed that type IV was the most frequent SCCmec type, which is in concordance with available data on nosocomial SCCmec type distribution in several countries (Vindel et al., 2009) MRSA isolates from northern Spain, a situation not described in other countries, but previously described in Spain. Globally, spa type t067-SCCmec type IV-ST125 (40.2 %) and t002-SCCmec type IV-ST5 (23.3 %) were predominant, both included in the complex spa-CC067 and ST-CC5.
More than 95 % of the isolates were multiresistant and more than 40 % were resistant to at least four antimicrobial agents. A high susceptibility to GEN and CLIN, the M phenotype of macrolide resistance, the presence of the ant(49)-Ia gene and the VAN and TEI susceptibility are remarkable in comparison with other studies (Vindel et al., 2009) .
A VAN MIC of 3 mg l 21 , defining resistance and intermediate resistance in accordance with European Committee on Antimicrobial Susceptibility Testing (EUCAST 2011; www.eucast.org/clinical_ breakpoints/) and the CLSI, respectively, was shown by 7.2 % of MRSA strains. A 'borderline' VAN MIC (¢1.5 mg l 21 ), which has been shown to be clinically associated with therapeutic failure (Kullar et al., 2011) , was shown by 91.4 % of the MRSA strains. Of note, all MRSA strains were susceptible to LNZ.
In conclusion, this study highlights the predominance of spa-CC067 and ST-CC5 (spa-t067 and t002) and of SCCmec IV in north Spain hospitals, the utility of spa-typing in short-term epidemiological surveillance, and a high prevalence (91.4 %) of MRSA isolates with a 'borderline' MIC for VAN (.1 mg l 21 ), which has been associated with a poor response to this antibiotic. 
